Reflex somatic testing for the detection of FGFR alterations in urinary tract carcinomas: A dual-institutional experience
American Journal of Clinical Pathology · 01.12.2025 · 164 (6) · 861-869
DOI: 10.1093/ajcp/aqaf108 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift American Journal of Clinical Pathology, online erschienen am 16.10.2025. Verfasst von Ngoc-Nhu Jennifer Nguyen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Urologic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To describe the prevalence and clinicopathologic associations of FGFR-altered urinary tract carcinomas in institutions incorporating reflex testing.
Methods
Next-generation sequencing was prospectively performed on urinary tract carcinomas for the detection of FGFR1-4 alterations at 2 tertiary care centers (2021-2025), using the Oncomine Comprehensive Assay (OCA) v3 DNA and OCA Plus RNA. Reflex testing was conducted on metastatic and/or advanced (pT3/4) carcinomas.
Results
The cohort included 366 patients (239 lower tract carcinomas, 72 upper tract carcinomas, and 55 metastases). Median age was 72.5 years (range, 36-97). Fifty-nine (16.1%) tumors were FGFR-altered. Forty-nine (13.4%) patients with actionable FGFR alterations (33 FGFR3 mutations, 13 FGFR3 fusions, and 3 FGFR2 mutations) were all 55 years or older (P = .097). The prevalence of actionable FGFR alterations was significantly higher in upper vs lower tract carcinomas (23.8% vs 13.8%, P = .007) and in lung metastases vs other metastatic sites (57.1% vs 10.4%, P = .002). A higher frequency was also seen in metastases vs primary tumors (16.4% vs 12.9%), although this difference did not reach statistical significance (P = .482). Actionable FGFR alterations were observed in urothelial carcinoma not otherwise specified (40/261) and in urothelial carcinoma with squamous differentiation (6/43), micropapillary features (2/11), or nested features (2/7).
Conclusions
The detection rate for FGFR1-4 alterations in a real-world, dual-institution cohort of urinary tract carcinomas was reported.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
- Department of Anatomic Pathology, Precision Diagnostics & Therapeutics Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
- Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.
ORCID-Profile: Ngoc-Nhu Jennifer Nguyen
Zitieren
APA
Nguyen, N. J., Olkhov-Mitsel, E., Craddock, K. J., Flood, T. A., & Downes, M. R. (2025). Reflex somatic testing for the detection of FGFR alterations in urinary tract carcinomas: A dual-institutional experience. American Journal of Clinical Pathology, 164(6), 861-869. https://doi.org/10.1093/ajcp/aqaf108
Vancouver
Nguyen NJ, Olkhov-Mitsel E, Craddock KJ, Flood TA, Downes MR. Reflex somatic testing for the detection of FGFR alterations in urinary tract carcinomas: A dual-institutional experience. American Journal of Clinical Pathology. 2025;164(6):861-869. doi:10.1093/ajcp/aqaf108
BibTeX
@article{Nguyen2025,
author = {Nguyen, Ngoc-Nhu Jennifer and Olkhov-Mitsel, Ekaterina and Craddock, Kenneth J and Flood, Trevor A and Downes, Michelle R},
title = {Reflex somatic testing for the detection of FGFR alterations in urinary tract carcinomas: A dual-institutional experience},
journal = {American Journal of Clinical Pathology},
year = {2025},
volume = {164},
number = {6},
pages = {861--869},
doi = {10.1093/ajcp/aqaf108}
}
EUVIMED